Dr Brumatti said the combination of MDR1 inhibitors and SMAC-mimetics could also kill leukaemia ‘stem cells’, which are thought to be a source of cancer recurrence.
“This discovery is important, because it suggests the drug combination could provide long-term benefits for patients,” she said.
Dr Brumatti said community support was critical for this research.
“We were thrilled that more than 400 people supported this research, providing more than $80,000 for the project. It also provided encouragement for the research team – it was wonderful to know that so many people believed in us.”
Thank you to all the generous supporters who helped make this medical research breakthrough possible.